Dana-Farber Cancer Institute, Harvard University

Boston, Massachusetts 02215-6024

1 studies enrolling now · 4 studies all time

What they study most

Breast Neoplasms, Chronic Myeloid Leukemia, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent WHO Grade III Glioma, Squamous Cell Carcinoma, WHO Grade III Glioma

Studies at this site

• Combination Therapy for the Treatment of Diffuse Midline Gliomas — Recruiting now
• Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas — Stopped early
• Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer — Completed
• Patient Reported Outcomes in Chronic Myeloid Leukemia — Completed